{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:25:00Z","timestamp":1793125500635,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015268","name":"Solvay Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.atherosclerosis.2011.06.029","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T18:23:40Z","timestamp":1309112620000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Does microvascular disease predict macrovascular events in type 2 diabetes?"],"prefix":"10.1016","volume":"218","author":[{"given":"R.S.","family":"Rosenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1997.00440340025002","article-title":"The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature","volume":"157","author":"Dineen","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0020","first-page":"S10","article-title":"Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial","volume":"63","author":"Grimm","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate","volume":"144","author":"Rahman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diacare.16.1.82","article-title":"Mortality of Mexican Americans with NIDDM. Retinopathy and other predictors in Starr County, Texas","volume":"16","author":"Hanis","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0035","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","article-title":"The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis","volume":"26","author":"Maser","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0040","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc06-2558","article-title":"Incidence of coronary heart disease in type 2 diabetic men and women. Impact of microvascular complications, treatment, and geographic location","volume":"30","author":"Avogaro","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0045","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.STR.0000260100.71665.2f","article-title":"Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study","volume":"38","author":"Giorda","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0050","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1464-5491.2007.02145.x","article-title":"Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus","volume":"24","author":"Tong","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0055","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2007.11.076","article-title":"Diabetic retinopathy and risk of heart failure","volume":"51","author":"Cheung","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1464-5491.2007.02327.x","article-title":"Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"25","author":"Targher","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0065","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc07-0264","article-title":"Diabetic retinopathy and the risk of coronary heart disease. The Atherosclerosis Risk in Communities Study","volume":"307","author":"Cheung","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc06-1747","article-title":"Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women","volume":"30","author":"Juutilainen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.STR.0000254547.91276.50","article-title":"Is diabetic retinopathy an independent risk factor for ischemic stroke?","volume":"38","author":"Cheung","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/dc07-1926","article-title":"Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT)","volume":"31","author":"Reaven","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0085","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1464-5491.2008.02592.x","article-title":"Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16","volume":"25","author":"Yokoyama","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2840-6-37","article-title":"Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients\u2014the Hong Kong diabetes registry","volume":"6","author":"Yang","year":"2007","journal-title":"Cardiovasc Diabet"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-007-0616-1","article-title":"Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study","volume":"50","author":"Bruno","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00125-005-0050-1","article-title":"Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women","volume":"49","author":"Juutilainen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0105","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2337\/dc06-0248","article-title":"Glomerular filtration rate, cardiorenal end points and all-cause mortality in type 2 diabetic patients","volume":"29","author":"So","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.diabres.2003.10.018","article-title":"Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes","volume":"64","author":"Gimeno-Orna","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0115","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.09.006","article-title":"Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria","volume":"44","author":"Knobler","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-8227(03)00035-4","article-title":"Causes of death, incidence and risk factors of cardiovascular diseases in Thai type 2 diabetic patients: a 5 year follow-up study","volume":"60","author":"Leelawattana","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1023\/A:1007673123716","article-title":"Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects","volume":"16","author":"Casiglia","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archinte.159.10.1097","article-title":"Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29","volume":"159","author":"Davis","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc06-1273","article-title":"Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry","volume":"30","author":"Yang","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0160","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc08-1079","article-title":"Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry","volume":"31","author":"Yang","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0165","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00125-004-1490-8","article-title":"Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients","volume":"47","author":"Thomas","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1056-8727(02)00206-4","article-title":"Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study","volume":"17","author":"Cardoso","year":"2003","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2003-40466","article-title":"Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study","volume":"111","author":"Linnemann","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/003655100750046486","article-title":"QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes","volume":"60","author":"Christensen","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1464-5491.2008.02567.x","article-title":"Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with type 2 diabetes: a 7-year follow-up study","volume":"25","author":"Ko","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autneu.2003.07.001","article-title":"Diabetic autonomic neuropathy is associated with an increased incidence of strokes","volume":"108","author":"Cohen","year":"2003","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00125-006-0483-1","article-title":"QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up","volume":"50","author":"Stettler","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8227(02)00128-6","article-title":"Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes","volume":"58","author":"Wheeler","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2337\/diacare.29.02.06.dc05-1242","article-title":"Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Astrup","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc07-1615","article-title":"Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA\/KORA Augsburg Cohort Study","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0215","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/dc08-0682","article-title":"Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study","volume":"31","author":"Ko","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0220","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2337\/dc08-1250","article-title":"Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden","volume":"32","author":"K\u00e4rvestedt","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0230","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.diabres.2008.06.020","article-title":"Effects of reduced coronary flow reserve on left ventricular function in type 2 diabetes","volume":"82","author":"Yonaha","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2008.02.016","article-title":"Impaired coronary flow reserve in patients with metabolic syndrome","volume":"201","author":"Pirat","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2007.03.002","article-title":"The additional prognostic power of diabetes mellitus on coronary flow reserve in patients with suspected coronary artery disease","volume":"78","author":"Nemes","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0245","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jacc.2007.06.027","article-title":"Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria","volume":"50","author":"Cortigiani","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0250","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0255","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MBC.0b013e3282f09dce","article-title":"Effect of postprandial hyperglycaemia on blood viscosity in aged patients suffering from type 2 diabetes as compared with healthy volunteers","volume":"18","author":"Coppola","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/CH-2010-1274","article-title":"Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy","volume":"44","author":"Bhavsar","year":"2010","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0265","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9149(72)90505-X","article-title":"Microcirculation and coronary blood flow","volume":"29","author":"Wells","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.06.029_bib0275","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Eng J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501100551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501100551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:32:17Z","timestamp":1758155537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501100551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S002191501100551X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.029","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does microvascular disease predict macrovascular events in type 2 diabetes?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}